Advertisement
THC vs UHS
Which Stock Would AI Choose? Tenet Healthcare (THC) vs. Universal Health Services (UHS) Stock Comparison
Key Takeaways
- Both THC and UHS operate in the acute care hospital sector, with THC emphasizing ambulatory surgery center (ASC) expansion and UHS maintaining a broader behavioral health presence.
- Recent market activity shows THC benefiting from strong first-quarter 2026 results and ongoing acquisition activity, while UHS reported a dividend declaration and upcoming second-quarter earnings.
- Both companies are scheduled to release second-quarter 2026 earnings in late July 2026, providing near-term catalysts for investor sentiment.
- Sector exposure remains similar, with performance influenced by reimbursement trends, labor costs, and patient volume recovery in healthcare services.
- Relative positioning highlights trade-offs between THC’s growth-oriented ambulatory strategy and UHS’s established scale and dividend policy.
- Market sentiment reflects cautious optimism ahead of earnings, with both stocks sensitive to broader healthcare policy and economic indicators.
Introduction
Tenet Healthcare Corporation (THC) and Universal Health Services, Inc. (UHS) represent two prominent players in the U.S. hospital and healthcare services industry. This comparison examines their business models, recent performance trends, and market positioning to assist institutional and retail investors evaluating relative value within the healthcare sector. Traders monitoring earnings catalysts, sector rotation, or AI-driven signals may find the analysis particularly relevant for assessing short- to medium-term opportunities in hospital operators.
THC Overview and Recent Performance
Tenet Healthcare Corporation (THC) operates a diversified portfolio of hospitals and ambulatory surgery centers, with a strategic emphasis on expanding its United Surgical Partners International (USPI) segment. In recent weeks, the stock has reflected positive sentiment following robust first-quarter 2026 financial results, including year-over-year growth in adjusted earnings per share and consolidated adjusted EBITDA. The company completed multiple ASC acquisitions, deploying capital toward high-margin outpatient procedures. Recent market activity has been shaped by anticipation of second-quarter 2026 earnings scheduled for July 24, 2026, alongside broader sector tailwinds from improving patient volumes and operational discipline.
UHS Overview and Recent Performance
Universal Health Services, Inc. (UHS) manages acute care hospitals, behavioral health facilities, and ambulatory services across the United States. Recent market activity has featured a declared quarterly dividend of $0.20 per share payable in September 2026, underscoring the company’s capital return policy. The firm is set to report second-quarter 2026 results on July 27, 2026. Performance in recent weeks has been influenced by ongoing operational execution in a competitive reimbursement environment, with investor focus centered on volume trends and cost management ahead of the earnings release.
Trending AI Robots
Tickeron maintains a curated Trending AI Robots section that highlights select AI trading bots from hundreds available across thousands of tickers. Only those demonstrating strong alignment with prevailing market conditions, consistent performance metrics, and suitable risk profiles earn placement in this dynamic listing. Available bots span a wide range of trading styles, strategies, timeframes, and performance statistics, allowing users to review detailed backtested results and ticker-specific suitability. The section provides transparent access to bot statistics such as win rates, drawdowns, and trade frequency ranges to support informed evaluation. Visit Trending AI Robots to explore current offerings.
Head-to-Head Comparison
In business model terms, THC pursues aggressive growth through ambulatory surgery center acquisitions, while UHS balances acute care with a substantial behavioral health footprint, offering different exposure to outpatient versus inpatient demand. Growth drivers contrast THC’s capital deployment into higher-margin procedures against UHS’s emphasis on dividend sustainability and operational scale. Recent momentum has favored THC following its first-quarter results, whereas UHS has drawn attention through its dividend announcement. Risk factors include reimbursement pressures and labor costs for both, though THC carries additional integration risk from acquisitions. Sector exposure remains comparable within healthcare services, yet market sentiment differentiates the two based on earnings timing and capital allocation priorities.
Tickeron AI Verdict
Based on observable factors including recent earnings momentum, acquisition-driven growth visibility, and positioning ahead of second-quarter results, Tickeron’s AI would currently assign a modestly higher probability of favorable near-term trend consistency to THC. UHS presents a more stable profile supported by its dividend and scale, potentially appealing in periods of heightened volatility. The assessment remains probabilistic and subject to earnings outcomes and broader market conditions.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is THC is a StrongBuy and UHS is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
THC’s FA Score shows that 2 FA rating(s) are green whileUHS’s FA Score has 1 green FA rating(s).
- THC’s FA Score: 2 green, 3 red.
- UHS’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
THC’s TA Score shows that 6 TA indicator(s) are bullish while UHS’s TA Score has 6 bullish TA indicator(s).
- THC’s TA Score: 6 bullish, 4 bearish.
- UHS’s TA Score: 6 bullish, 4 bearish.
Price Growth
THC (@Hospital/Nursing Management) experienced а +9.25% price change this week, while UHS (@Hospital/Nursing Management) price change was +8.15% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +0.13%. For the same industry, the average monthly price growth was -2.49%, and the average quarterly price growth was +34.09%.
Reported Earning Dates
THC is expected to report earnings on Nov 03, 2026.
UHS is expected to report earnings on Oct 28, 2026.
Industries' Descriptions
@Hospital/Nursing Management (+0.13% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
| THC | UHS | THC / UHS | |
| Capitalization | 20.5B | 10.2B | 201% |
| EBITDA | 5.58B | 2.8B | 199% |
| Gain YTD | 28.211 | -22.559 | -125% |
| P/E Ratio | 9.85 | 6.88 | 143% |
| Revenue | 22.6B | 17.8B | 127% |
| Total Cash | 2.17B | N/A | - |
| Total Debt | 13.2B | 5.13B | 258% |
THC | UHS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 44 | 38 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 73 Overvalued | 12 Undervalued | |
PROFIT vs RISK RATING 1..100 | 19 | 85 | |
SMR RATING 1..100 | 20 | 43 | |
PRICE GROWTH RATING 1..100 | 36 | 50 | |
P/E GROWTH RATING 1..100 | 53 | 76 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
UHS's Valuation (12) in the Hospital Or Nursing Management industry is somewhat better than the same rating for THC (73). This means that UHS’s stock grew somewhat faster than THC’s over the last 12 months.
THC's Profit vs Risk Rating (19) in the Hospital Or Nursing Management industry is significantly better than the same rating for UHS (85). This means that THC’s stock grew significantly faster than UHS’s over the last 12 months.
THC's SMR Rating (20) in the Hospital Or Nursing Management industry is in the same range as UHS (43). This means that THC’s stock grew similarly to UHS’s over the last 12 months.
THC's Price Growth Rating (36) in the Hospital Or Nursing Management industry is in the same range as UHS (50). This means that THC’s stock grew similarly to UHS’s over the last 12 months.
THC's P/E Growth Rating (53) in the Hospital Or Nursing Management industry is in the same range as UHS (76). This means that THC’s stock grew similarly to UHS’s over the last 12 months.
| THC | UHS | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 65% | 3 days ago 38% |
| Stochastic ODDS (%) | 3 days ago 62% | 3 days ago 56% |
| Momentum ODDS (%) | 3 days ago 79% | 3 days ago 66% |
| MACD ODDS (%) | 3 days ago 76% | 3 days ago 62% |
| TrendWeek ODDS (%) | 3 days ago 79% | 3 days ago 65% |
| TrendMonth ODDS (%) | 3 days ago 76% | 3 days ago 66% |
| Advances ODDS (%) | 6 days ago 82% | 5 days ago 69% |
| Declines ODDS (%) | 4 days ago 67% | 12 days ago 69% |
| BollingerBands ODDS (%) | 3 days ago 53% | 3 days ago 46% |
| Aroon ODDS (%) | 3 days ago 84% | 3 days ago 64% |
Advertisement
UHS and
Correlation & Price change
A.I.dvisor indicates that over the last year, UHS has been loosely correlated with HCA. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if UHS jumps, then HCA could also see price increases.
| Ticker / NAME | Correlation To UHS | 1D Price Change % | ||
|---|---|---|---|---|
| UHS | 100% | +3.15% | ||
| HCA - UHS | 65% Loosely correlated | +1.72% | ||
| THC - UHS | 58% Loosely correlated | +0.81% | ||
| ENSG - UHS | 41% Loosely correlated | -0.37% | ||
| EHC - UHS | 40% Loosely correlated | +0.16% | ||
| PNTG - UHS | 40% Loosely correlated | -1.97% | ||
More | ||||